Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Colorectal Cancer Metastatic × Vemurafenib × Clear all

Phase

Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 5 Multiple Myeloma 1 Colorectal Cancer Metastatic 1 Advanced BRAF-mutant Cancers 1

Interventions

Capecitabine 6 Bevacizumab 5 trifluridine tipiracil drug combination 3 Cetuximab 3 Oxaliplatin 2 sintilimab 1 monoclonal antibody YYB-101 1 aflibercept 1 Vemurafenib 1 Nivolumab 1 LY-2157299 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04790448 2023-02-15

Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer

Sun Yat-sen University

Phase 1/2 Completed

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡